Hepatitis C virus non structural fusion protein

Details for Australian Patent Application No. 2007222580 (hide)

Owner Transgene S.A.

Inventors Chatel, Laurence; Fournillier, Anne; Inchauspe, Genevieve; Penin, Francois

Agent Shelston IP

Pub. Number AU-B-2007222580

PCT Pub. Number WO2007/101657

Priority 06360006.8 09.03.06 EP

Filing date 6 March 2007

Wipo publication date 13 September 2007

Acceptance publication date 19 April 2012

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

Event Publications

28 August 2008 PCT application entered the National Phase

  PCT publication WO2007/101657 Priority application(s): WO2007/101657

19 April 2012 Application Accepted

  Published as AU-B-2007222580

16 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007222584-Anti-drug antibody assay

2007222577-Display and operator communication system